The role of noncoding "junk DNA" in cardiovascular disease.

K. Vickers,Brian T Palmisano,A. Remaley

DOI: https://doi.org/10.1373/clinchem.2010.147603

IF: 12.114

2010-10-01

Clinical Chemistry

Abstract:The complete sequencing of the human genome has revealed many mysteries on how aberrations in gene structure and regulation contribute to disease. One of the most unforeseen and potentially revolutionary findings since the complete annotation of the human genome is the complexity of noncoding DNA. What was once considered “junk DNA” now holds the keys to many novel gene regulatory mechanisms, and genetic variation within these regions likely accounts for a major portion of disease susceptibility. Until recently, the biochemical mechanisms linking noncoding DNA, which does not encode any proteins, to the pathogenesis of disease were largely unknown, but there has been a torrent of new information in this field that has the prospect of changing how we diagnose and treat patients. An interesting example of how noncoding DNA can regulate gene expression and increase cardiovascular disease risk was recently reported by Visel et al. in Nature (1). Many previous studies have identified a strong association between a genetic locus on 9p21 with cardiovascular disease outcomes, but the cause for this association was unknown. In some populations, as many as 25% of individuals harbor the risk allele, which increases cardiovascular risk as much as 3-fold. The report by Visel et al. (1) suggests that a distal noncoding DNA element located in 9p21 controls vascular gene expression and may account for its association with cardiovascular disease. Mice with an orthologous deletion of a 70-kbp segment in chromosome 4, which corresponds to the 9p21 region in humans, had increased weight gain and mortality on a high-fat diet. Deletion of this region also caused the selective loss of expression of 2 adjacent genes that lie approximately 100 kbp outside of the deletion. The 2 genes affected by the deletion are the cyclin-dependent kinase inhibitor genes Cdkn2a 2 (cyclin-dependent kinase inhibitor 2A) and Cdkn2b …

Biology,Medicine